Latent Autoimmune Diabetes in Adults Associated with Von Recklinghausen’s Disease (Neurofibromatosis Type 1)
DOI:
https://doi.org/10.12970/2310-9874.2018.06.01Keywords:
Latent Autoimmune Diabetes in Adults, LADA, neurofibromatosis type 1, Von Recklinghausen’s Disease, diabetes mellitus.Abstract
Introduction: Endocrine disorders during Von Recklinghausen’s Disease or neurofibromatosis type 1 (NF1) are rare and particularly observed in children. However, autoimmune diabetes mellitus (DM) remains exceptional and unusual during this phacomatosis. We report an original case of Latent Autoimmune Diabetes in Adults (LADA) associated with NF1.
Case Report: A 32-year-old Tunisian male, known to have NF1 since childhood, was admitted for significant recent weight loss (10 kg in one month) with high blood glucose levels. The biological tests confirmed the diagnosis of DM with marked ketoacidosis: fast blood glucose at 16 mmol/l, postprandial glucose at 21 mmol/l, and HbA1c at 9.9%. Radiological and endoscopic investigations did not indicate pancreatic and/or duodenal tumors. Anti-GAD and anti-IA2 autoantibodies were positively confirming the diagnosis of LADA. The assessment of degenerative complications and screening for possible other autoimmune diseases were negative. The evolution was favorable under intensive insulinotherapy.
Conclusion: The association of DM type 1 with NF1 remains exceptional and only four cases are found in the literature, all pediatrics. Our observation is, to our knowledge, the first reporting this association in adult (LADA with NF1).
References
Bizzarri C, Bottaro G. Endocrine implications of neurofibromatosis 1 in childhood. Horm Res Paediatr 2015; 83(4): 232-41. https://doi.org/10.1159/000369802
Sabol Z, Kipke-Sabol L. Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene. Lijec Vjesn 2005; 127(11-12): 303- 11.
Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol 2009; 61(1): 1-14. https://doi.org/10.1016/j.jaad.2008.12.051
Kamoun M, Charfi N, Rekik N, Mnif MF, Mnif F, Kmiha H, et al. Neurofibromatosis and Type 1 diabetes mellitus: an unusual association. Diabet Med 2009; 26(11): 1180-1. https://doi.org/10.1111/j.1464-5491.2009.02848.x
Zaka-ur-Rab Z, Chopra K. Diabetes melliitus in neurofibromatosis I: an unusual presentation. Indian Pediatr 2005; 42(2): 185-6.
Ozhan B, Ozguven AA, Ersoy B. Neurofibromatosis type 1 and diabetes mellitus: an unusual association. Case Rep Endocrinol 2013; 2013: 689107.
Sani I, Albanese A. Endocrine Long-Term Follow-Up of Children with Neurofibromatosis Type 1 and Optic Pathway Glioma. Horm Res Paediatr 2017; 87(3): 179-188. https://doi.org/10.1159/000458525
Martins AS, Jansen AK, Rodrigues LOC, Matos CM, Souza MLR, Miranda DM, et al. Increased insulin sensitivity in individuals with neurofibromatosis type 1. Arch Endocrinol Metab 2018; 62(1): 41-46. https://doi.org/10.20945/2359-3997000000007
Madubata CC, Olsen MA, Stwalley DL, Gutmann DH, Johnson KJ. Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis. Genet Med 2015; 17(1): 36- 42. https://doi.org/10.1038/gim.2014.70
Masocco M, Kodra Y, Vichi M, Conti S, Kanieff M, Pace M, et al. Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006). Orphanet J Rare Dis 2011 Mar 25; 6: 11. https://doi.org/10.1186/1750-1172-6-11
Rasmussen SA, Yang Q, Friedman JM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 2001; 68(5): 1110-8. https://doi.org/10.1086/320121
Martins AS, Jansen AK, Rodrigues LO, Matos CM, Souza ML, de Souza JF, et al. Lower fasting blood glucose in neurofibromatosis type 1. Endocr Connect 2016; 5(1): 28-33. https://doi.org/10.1530/EC-15-0102
Halpern SR, Fashena G J. Von Recklinghausen’s Disease with Diabetes Mellitus. JCEM 1941; 1(9): 726-7.
Naqash M, Naik M, Bhat T, Yusuf I, Khan AW, Suhaff A. Recurrent hypoglycemia in a patient of neurofibromatosis type 1 and type 1 diabetes mellitus: Munchausen's syndrome mimicking Insulinoma. J Mental Health Hum Behav 2015; 20: 32-4. https://doi.org/10.4103/0971-8990.164820
Zaki A, Asiri A, Al-Agha AE. Neurofbromatosis and type-1 diabetes in a seven-year-old child: A rare combination. Curr Pediatr Res 2018; 22 (2): 172-176.
HiesgenI J, VariavaI E. Neuroendocrine tumour in a patient with neurofibromatosis type 1 and HIV. S Afr J HIV Med 2015; 16(1): 323. https://doi.org/10.4102/sajhivmed.v16i1.323
Swinburn BA, Yeong ML, Lane MR, Nicholson GI, Holdaway IM. Neurofibromatosis associated with somatostatinoma: a report of two patients. Clin Endocrinol (Oxf) 1988; 28(4): 353- 9. https://doi.org/10.1111/j.1365-2265.1988.tb03666.x
Griffiths DF, Williams GT, Williams ED. Multiple endocrine neoplasia associated with von Recklinghausen's disease. Br Med J (Clin Res Ed) 1983; 287(6402): 1341-3. https://doi.org/10.1136/bmj.287.6402.1341
Hegedus B, Yeh TH, Lee DY, Emnett RJ, Li J, Gutmann DH. Neurofibromin regulates somatic growth through the hypothalamic–pituitary axis. Human Molecular Genetics 2008; 17: 2956-2966. https://doi.org/10.1093/hmg/ddn194
